Australia Stock Alert

AUSTR

CLOSING UPDATE: CSL hits 52-week high third time in one month August 17, 2018 16:00:00 AEST

NEWS BITES - AUSTRALIA

This is an end of day Alert, produced after today's Australian market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

CSL, Australia's largest pharmaceuticals & biotechnology company by market capitalisation, hit a 52-week high of $A217.74 today for the third time in the past one month and last traded at $A215.85. Trading volume was 1.4 times average at the end of the day. Compared with the All Ordinaries Index which rose 13.6 points (or 0.2%) in the day, this represented a relative price change of -0.7%.

Technical indicators complementing today's significant uptrend:

+ The positive 4.08 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

+ The stock has outperformed 91% of the Australian market over the past 6 months.

+ In the last one month the stock has hit a new 52-week high thrice and in the last three months seventeen times, pointing to a significant uptrend.

+ The present value of AUD1,000 invested one year ago is $A1,744 [vs $A1,103 for the All Ordinaries Index].

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

+ Return on Equity 42.3% [19.6%]

+ Return on Assets 14.7% [8.7%]

+ Return on Capital Employed 23.7% [14.4%]

+ Year-on-Year Earnings Growth of 9.6% [7.3%]

Other Bullish Signals include:

+ Interest cover is less leveraged at 19.8 times.

+ Total Liabilities/EBITDA of 3.3 is comfortably below the Joseph Piotroski benchmark of <5.

+ Net profit margin has averaged 21.6% in the last 3 years. This is considered superior and suggests a high margin of safety.

+ As per the Du Pont analysis, Return on Equity is high at 42.3%.

Note

Bearish Signals:

Tobin's Q Ratio is 7.8. Compared with the rest of the market the stock is overvalued and ranks in the bottom 8% of stocks by value of Q Ratio.

Overbought/Bearish:

The 0.9% discount to 12-month high of $A217.74 against the 73.8% premium to 12-month low of $A124.21 suggests the climb might be peaking.

TODAY'S ALERTS

Afternoon Alert: CSL hits 52-week high third time in one month

August 17, 2018 13:00:00 AEST

CSL Limited (ASX:CSL) hit a 52-week high of $A217.74 today for the third time in the past one month and last traded at $A215.20.

Morning Alert: CSL hits 52-week high third time in one month

August 17, 2018 11:00:00 AEST

CSL Limited (ASX:CSL) hit a 52-week high of $A217.74 today for the third time in the past one month and last traded at $A216.37.

RECENT ALERTS

CLOSING UPDATE: CSL increases further 0.8%, led S&P/ASX 200 Health Care index higher

August 16, 2018 16:00:00 AEST

CSL, Australia's largest pharmaceuticals & biotechnology company by market capitalisation, has increased 1.1% to trade at $A216.91 vs. the S&P/ASX 200 Health Care index which strengthened 233.8 points (or 0.7%) to 32,788.3. Representing a weighting of about 55.3% of the index, the stock accounted for 83.7% of today's gain. The shares have outperformed 90% of the market in the past week. Trading volume was 1.8 times average at the end of the day. Compared with the All Ordinaries Index which fell 3.1 points (or 0.05%) in the day, this represented a relative price increase of 1.3%.

Afternoon Alert: CSL increases 0.3%, leads Pharmaceuticals & biotechnology sector higher

August 16, 2018 13:00:00 AEST

CSL Limited (ASX:CSL) has increased 0.3% to trade at $A215.26 vs. the Pharmaceuticals & biotechnology sector which strengthened 85.0 points (or 0.3%) to 25,820.8. Representing a weighting of about 90.8% of the sector, the stock accounted for 88.1% of today's gain. The shares have outperformed 89% of the market in the past week.

CSL Limited (AU:CSL; ASX:CSL; AX:CSL)

ISIN: AU000000CSL8

PermID: 4295856855

Source: www.BuySellSignals.com